Limitations of conventional therapies Modern pharmacological strategies for GI disorders rely on drugs such as antacids, proton pump inhibitors (PPIs), H 2 receptor antagonists, anti-inflammatory agents, antibiotics, and laxatives
The company's decision to advance both programs suggests confidence that the GLP-1/amylin dual pathway represents the future of obesity pharmacotherapy, with room for multiple formulations serving different patient preferences
TB-500 accelerates healing
Topical copper peptides may help this look when the main driver is dermal thinning, but they work slowly and need steady use over months, not days
and nephrotoxicity (compounds 4 , 26 , 27 , 29 , 34 , and 48 50 ), with moderate relevance
Acknowledgements The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through a Large Research Project under grant number RGP2/580/45